Aro Biotherapeutics

CIC Philadelphia

3675 Market Street, Suite 200

Philadelphia, PA 19104

Email: info@arobiotx.com 

Aro LinkedIn

© 2018 Aro Biotherapeutics Company. All Rights Reserved.

ABOUT ARO

Aro Biotherapeutics is focused on the development of a new protein drug platform called Centyrins, designed to achieve better efficacy and safety profiles for patients with cancer and other serious diseases.

CENTYRIN PLATFORM

Centyrins are designed to achieve new therapeutic mechanisms by simultaneously targeting multiple cell surface receptors and delivering complex drug payloads to specific cell types and tissues.

 

LATEST NEWS

February 11, 2020

Aro Biotherapeutics Appoints Leading Cancer Biologist Dr. Martin McMahon and Protein Structure and Design Expert Dr. Ronald Swanson to its Scientific Advisory Board